MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
about
MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.Effects of miR-338 on morphine tolerance by targeting CXCR4 in a rat model of bone cancer pain.TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
P2860
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
@en
type
label
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
@en
prefLabel
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
@en
P2093
P2860
P1476
MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11010-014-2211-3
P577
2014-09-10T00:00:00Z
P6179
1011883776